Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - As a real-time PCR rapid test at the point of care (POC), the Vivalytic test MRSA/SA can detect two of the most important pathogens associated with hospital-acquired infections. - Differentiation as to whether the bacterial ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - New real-time PCR rapid test for detection of four STI - First Vivalytic test in cooperation with development partner BioGX - Positive test results available within an hour directly at the point of care Bosch Healthcare ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - SARS-CoV-2 detection of the Vivalytic tests from Bosch Healthcare Solutions GmbH is not affected by the mutations that were first identified in the UK and South Africa (VOC 202012/01, B.1.1.7.; 501Y.V2, B.1.351). As the tests ...To the press release of Bosch Healthcare Solutions GmbH
Stuttgart, Germany (ots) - Cloud-based software update means a faster PCR test for SARS-CoV-2 - Improved software for Vivalytic: turnaround time for positive SARS-CoV-2 samples reduced to under 30 minutes. - Expansion of production: Launch of two ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - Rapid test is particularly suited to decentralized use in mobile test centers. - Sensitivity: 98 percent, specificity: 100 percent. - Simultaneous testing of five people with one cartridge by pooling will also be possible as of ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - Bosch Healthcare Solutions and BioGX announce partnership for point of care molecular tests - Partnership will accelerate planned expansion of the test portfolio for the Vivalytic all-in-one platform Bosch Healthcare Solutions ...To the press release of Bosch Healthcare Solutions GmbH
Waiblingen (ots) - - One of the world's first multiplex molecular diagnostic tests that can identify COVID-19 and distinguish it from nine other respiratory infections with similar symptoms, like influenza - The test meets the requirements of the ...To the press release of Bosch Healthcare Solutions GmbH
